Top compounds associated with response to CHRD


Feature Type Standardized
Nominal ANOVA
mRNA UNC0321 CTRPv2 pan-cancer AAC -0.041 0.3
mRNA Imatinib CTRPv2 pan-cancer AAC -0.04 0.3
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.035 0.3
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.035 0.3
mRNA Methotrexate CTRPv2 pan-cancer AAC -0.04 0.3
mRNA BRD-K35604418 CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC 0.081 0.3
mRNA WP1130 CTRPv2 pan-cancer AAC 0.039 0.3
mRNA BRD-K99006945 CTRPv2 pan-cancer AAC -0.057 0.3
mRNA barasertib CTRPv2 pan-cancer AAC -0.035 0.3
Download CSV